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INTRODUCTION
Mitochondrial disease (MD) is a hereditary or sporadic multi-
systemic disorder resulting from the impairment of mitochon-
drial energy metabolism in the respiratory chain complex of 
the mitochondrial inner membrane.1,2 The heart is one of the 
most commonly affected organs, because the myocardium 
requires a high level of oxygen metabolism to supply blood and 
energy substrates.1-3 In addition, mitochondria have a signifi-
cant role in the energy production of cardiac cellular biogenic 
arrangements. Energy supplied in the form of adenosine tri-
phosphate (ATP) is essential in sustaining cardiac contractility 
and relaxation functions. 
MD can result in structural heart lesions, which may affect 
the myocardium, coronary arteries, pericardium, or aortic root. 
Cardiovascular functional abnormalities can also occur, includ-
ing impulse generation, conduction abnormalities, systolic 
dysfunction, heart failure, pulmonary hypertension, and auto-
nomic dysfunction.1 The most frequent cardiovascular mani-
festation is cardiomyopathy (CMP), which presents as hypertro-
phic CMP (HCMP), dilated CMP, restrictive CMP, or unclassified 
CMP resembling left ventricular hypertrabeculation or non-
compaction. Myocardial fibrosis and late enhancement are 
also present in other cardiomyopathies.1-3 
Children and infants with MD have different clinical pre-
sentations to people with adult-onset MD. In children and in-
fants, MD is often correlated with genetic defects. The pheno-
types of patients with pediatric MD are much more severe, often 
involving the brain and multi-systemic disorders, but seldom 
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isolated myopathy. The frequency of cardiovascular involve-
ment may differ between children and adults. 
With the above in mind, the purpose of this study was to in-
vestigate cardiovascular function in children with MD, to as-
sess conventional and advanced echocardiographic data, to 
distinguish unique myocardial characteristics, and to identify 
early myocardial deterioration. 
MATERIALS AND METHODS
Patients
We retrospectively reviewed the medical records of 33 children 
with MD who were treated at Gangnam Severance Hospital 
between March 2013 and June 2014. An equal number of heal-
thy, age-matched children were enrolled to serve as a control 
group. 
All patients with MD satisfying the modified MD criteria 
proposed by Bernier, et al.4 were enrolled; mitochondrial respi-
ratory chain complex defects were confirmed via muscle tissue 
biochemical enzyme assay. The mitochondrial enzyme func-
tion of isolated mitochondria was assessed using a standard 
spectrophotometric assay as described by Rustin, et al.5 Nico-
tinamide adenine dinucleotide, coenzyme Q (CoQ) reductase 
(complex I), succinate-CoQ reductase (complex II), succinate-
cytochrome c reductase (complex II–III), cytochrome c reduc-
tase (complex III), cytochrome c oxidase (complex IV), oligo-
mycin-sensitive ATPase (complex V), and citrate synthase 
activity were also evaluated. Patients were diagnosed with mi-
tochondrial respiratory chain complex defects when the resid-
ual enzyme activity was <20% of that in the age-matched con-
trol group. 
The demographic characteristics of patients were collected 
from their medical records. The control group of children com-
prised those from echocardiographic referral for precordial 
cardiac murmur, an enlarged cardiothymic silhouette in a chest 
radiogram, or an incomplete right bundle branch block pat-
tern on an electrocardiogram. Children with any acute illness by 
history and physical examination, congenital or acquired heart 
disease, syndromes, or chromosomal abnormalities were ex-
cluded.
All study participants underwent transthoracic echocardiog-
raphy. All procedures were approved by the Institutional Re-
view Board of Gangnam Severance Hospital in Seoul, Korea 
(3-2017-0168). Informed consent was obtained and all meth-
ods were performed in accordance with the relevant guidelines 
and ethics board regulations.
Echocardiography and strain analysis
Conventional echocardiographic measurements and advanced 
myocardial imaging studies were performed by an expert pe-
diatric cardiologist in both groups using a Siemens ACUSON 
SC2000 system (Siemens Medical Solutions USA, Inc., Moun-
tain View, CA, USA). Echocardiography was performed in the 
left lateral decubitus or supine position to obtain two-dimen-
sional, M-mode, and Doppler measurements of the paraster-
nal long-axis view, short-axis view, and four-chamber view, 
respectively. Maximal left ventricular wall thickness was de-
fined as the largest thickness in any single segment, mainly in 
the parasternal short-axis view. The mean value of more than 
three measurements obtained using echocardiography was 
entered into analysis. 
Advanced tissue speckle images were recorded at a rate of 
>50 frames/s to investigate myocardial strain and the rate 
thereof. Two-dimensional images of the apical four-chamber 
view were recorded to assess longitudinal strain, while those 
of the parasternal short-axis view were acquired to assess ra-
dial and circumferential strain. An offline speckle tracking pro-
cess was conducted with acoustic markers using Syngo Veloc-
ity Vector Imaging software (Siemens Medical Solution USA, 
Inc.). The borders of the endocardium and epicardium were 
traced manually and the border of the myocardium was defined 
as the midline between the border of the endocardium and 
epicardium. These three contours were tracked frame-by-frame 
throughout the cardiovascular cycle. Patients were diagnosed 
with myocardial deformation after this tracking process, while 
simultaneously checking for layer-specific myocardial strain 
and the respective strain rate of the layers of the endocardium, 
myocardium, and epicardium. 
Statistical analysis
All data and measurements were reported as means±standard 
deviations. We compared all demographic and echocardiogra-
phic data between the two groups using an independent Stu-
dent’s t-test. A p-value ≤0.05 was considered statistically sig-
nificant with a correlation r-value of ≥0.60 with SPSS 19.0 (IBM 
Corp., Armonk, NY, USA).
RESULTS
In total, 22 boys and 11 girls with a mean age of 10.3±4.0 years 
were included in the analysis. The control group included the 
same number of children (14 boys and 19 girls) with a mean age 
of 8.4±3.9 years (Table 1). The results of the spectrophotomet-
ric biochemical enzyme assays for mitochondrial respiratory 
chain complexes of the muscle were available in all patients: 
66.7% (n=22) of the patients had complex I defects and 33.3% 
(n=11) had complex IV defects. Among the children with MD, 
10 were capable of independent walking, eight were wheel-
chair-bound, and 15 were bed ridden.
The conventional echocardiographic measurements of left 
ventricular ejection fraction were similar between the two 
groups [MD, 65.8±9.8%; control, 65.9±4.2%; p=not significant 
(ns)]. The results of fractional shortening were also similar be-
tween groups (MD, 35.6±6.3%; control, 36.3±3.2%; p=ns). Pa-
130
Layer-Specific Strain Analysis in Children with MD
https://doi.org/10.3349/ymj.2018.59.1.128
tients with MD had greater interventricular septal and left ven-
tricular posterior wall thickness during diastole and systole 
than patients in the control group. However, this difference was 
not statistically significant (p=ns) (Table 2).
The conventional mitral inflow E, E/A, tissue Doppler dia-
stolic E' were significantly lower, and E/E' was higher in the 
MD group than those in the control group (p<0.05) (Table 2). 
These diastolic parameters did not correlate with wall thick-
ness in this study.
We noted no difference in longitudinal strain in the apical 
four-chamber view between the two groups in all layers of the 
endocardium, myocardium, and epicardium. Strain rate was 
not significantly different between the two groups in the apical 
four-chamber view (Table 3). 
Radial strain measured in the parasternal short-axis view was 
not statistically different between the groups (MD, 37.17±11.1%; 
control, 37.73±25.9%; p=0.924). Similarly, the radial strain rate 
was not significantly different between the groups (MD, 2.26± 
0.91; control, 2.44±0.84; p=0.562).
Circumferential strain in the endocardium (-22.62±4.7% vs. 
-24.67±5.3%; p=0.161), myocardium (-15.46±3.8% vs. -18.09± 
4.0%; p=0.008), and epicardium (-10.07±4.0% vs. -12.14±5.0%; 
p=0.042) was lower in patients with MD than in healthy pa-
tients. Circumferential strain rate of the myocardium was also 
lower in the MD group (-1.10±0.27) than that in the control 
group (-1.29±0.22) (p=0.038). The strain rate was lower in the 
endocardium (-1.74±0.38 vs. -1.82±0.27; p=0.444) and epicar-
dium (-0.81±0.38 vs. -0.91±0.27, p=0.231) of patients in the MD 
group than in patients in the control group, although the dif-
ference was not statistically significant (Table 4). Interestingly, 
the decreased circumferential strain of the endocardium, myo-
cardium, and epicardium in patients with MD correlated well 
with the tissue Doppler peak velocities of E’ (Figs. 1, 2, and 3). 
When these results were considered together, we found that 
the conventional echocardiographic diastolic values of mitral 
E, E/A, and tissue Doppler E’ were significantly lower in chil-
dren with MD than those in healthy children. In contrast, E/E’ 
was significantly higher in children with MD than that in he-
althy children. The advanced myocardial analysis revealed no 
significant differences in longitudinal and radial strain be-
tween the two study groups; however, the circumferential strain 
in patients with MD was significantly lower in the myocardium 
and epicardium. In addition, the circumferential strain in all 
three layers correlated with tissue Doppler E’. 
DISCUSSION
Hundreds of different pathogenic mitochondrial DNA muta-
tions have been reported in humans, many of which are asso-
ciated with various cardiovascular diseases. This wide range 
of disease expression and the lack of a specific cardiovascular 
phenotype distinctive to patients with MD presents a challenge 
for cardiologists, especially in pediatric patients.6 According to 
previously published studies, cardiac involvement was re-
Table 1. Baseline Patient Characteristics
MD (n=33) Control (n=33) p value
Sex (M:F) 22:11 14:19
Age (year) 10.3±4.0 8.4±3.9 0.069
Weight (kg) 30.0±12.7 30.0±16.6 0.531
MD, mitochondrial disease.
Table 2. Comparison of Echocardiographic Measurements between the 
Groups
MD (n=33) Control (n=33) p value
LV EF (%) 65.94±8.05 65.79±4.02   0.899
LV FS (%) 36.31±7.35 35.62±3.06   0.620
IVSTd (mm) 7.75±3.25 6.91±1.56   0.192
IVSTs (mm) 9.97±3.42 8.98±1.81   0.153
LVIDd (mm) 36.06±6.92 37.83±5.86   0.277
LVIDs (mm) 23.15±5.80 24.34±3.92   0.353
LV PWTd (mm) 6.06±2.09 5.63±1.57   0.364
LV PWTs (mm) 9.20±2.88 8.68±1.51   0.048
Mitral E (m/s) 0.98±0.20 1.08±0.16   0.029
Mitral A (m/s) 0.61±0.20 0.54±0.11   0.074
Mitral E/A 1.77±0.69 2.09±0.45   0.041
TDI E' (m/s) 0.11±0.03 0.14±0.02 <0.001
TDI A' (m/s) 0.08±0.11 0.05±0.02   0.230
TDI S' (m/s) 0.06±0.01 0.09±0.10   0.086
E/E' 8.88±2.26 7.62±1.64     0.0007
MD, mitochondrial disease; LV, left ventricle; EF, ejection fraction; FS, frac-
tional shortening; IVSTd, interventricular septal thickness, diastole; IVSTs, in-
terventricular septal thickness, systole; LVIDd, left ventricle internal diameter, 
diastole; LVIDs, left ventricle internal diameter, systole; PWTd, posterior wall 
thickness, diastole; PWTs, posterior wall thickness, systole; E, peak early mi-
tral inflow velocity; A, peak late mitral inflow velocity; TDI, tissue Doppler 
imaging; E’, peak early diastolic septal annulus velocity; A’, peak late diastol-
ic septal annulus velocity; S’, peak systolic septal annulus velocity. 
Table 3. Strain and Strain Rate in the Apical Four-Chamber View
Strain (%) MD Control p value Strain rate (1/s) MD Control p value
Radial   23.53   23.15 0.941 Radial   2.22   2.18 0.855
Longitudinal Longitudinal
Endocardium -18.83 -17.64 0.377 Endocardium -1.40 -1.25 0.313
Myocardium -15.50 -12.93 0.165 Myocardium -1.09 -1.00 0.220
Epicardium -12.23 -12.71 0.613 Epicardium -0.86 -0.85 0.768
MD, mitochondrial disease.
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ported in 33% of pediatric patients with MD, while CMP was 
present in approximately 5.6% of children with MD.1,7,8
Among the different types of CMP, HCMP is the most fre-
quently observed in patients with MD.1,9,10 Cardiac hypertro-
phy is an adaptive response to the increased work load induced 
by physiological or pathological stimuli to counteract the in-
creased wall tension and to maintain cardiac output.11 When the 
heart is extremely stressed with persistent overload, the result-
ing hypertrophy may become maladaptive, and cardiac func-
tion may progressively deteriorate, resulting in heart failure.12
Primary mitochondrial cardiomyopathies lead to mitochon-
drial proliferation in cardiomyocytes.13 In addition, pathologi-
cal cardiac hypertrophy that develops due to increasing num-
bers of mitochondria results in the enhancement of mitochon-
drial biogenesis and protein synthesis.14 To our knowledge, 
however, the implications of mitochondrial biogenesis in CMP 
have not been clarified. Furthermore, the hypertrophic phase 
induced in CMP that naturally accompanies increased mito-
chondrial biogenesis seems to delay the cardiac decompensa-
tion caused by pressure overload.15
Other experimental studies have reported the cardiovascu-
lar effects of prediabetes in patients with MD, indicating that 
mild diastolic dysfunction and cardiovascular hypertrophy are 
multifactorial phenomena associated with early changes in mi-
tophagy, cardiac lipid accumulation, and elevated oxidative 
stress.16 Prediabetes-induced oxidative stress was also shown 
to originate from the subsarcolemmal mitochondria.16
Severe and rapidly progressive dilated CMP has been shown 
Table 4. Strain and Strain Rate in the Parasternal Short-Axis View
Strain (%) MD Control p value Strain rate (1/s) MD Control p value
Radial   37.17   37.73 0.924 Radial   2.26   2.44 0.562
Circumferential Circumferential
Endocardium -22.62 -24.67 0.161 Endocardium -1.74 -1.82 0.444
Myocardium -15.46 -18.09 0.008 Myocardium -1.10 -1.29 0.038
Epicardium -10.07 -12.14 0.042 Epicardium -0.81 -0.91 0.231
MD, mitochondrial disease.
Fig. 1. Correlation of circumferential strain of the endocardial layer with conventional and tissue Doppler parameters.
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to occur if the hypertrophic phase is bypassed.17 Since cardio-
vascular systolic and diastolic function is dependent on mito-
chondrial ATP, it is possible that a decline in mitochondrial bio-
genesis contributes to the progression of CMP and heart 
failure, leading to sudden cardiovascular death. 
Many questions still remain to be answered, however. The 
reason why CMP is the most common form of cardiac involve-
ment in MD may be due to the close relationship between 
myocardial function and mitochondrial energy supply. Addi-
tionally, the similarities between skeletal muscle and the myo-
cardium may play a role, with the former being the most fre-
quently affected organ due to its need for constant energy 
supply and the latter being the tissue with potentially the great-
est energy requirement.1 HCMP is most prevalent in children 
with MD and develops even without the presence of systolic 
dysfunction or heart failure.8
In the present study, we identified an increase in the left ven-
tricular posterior wall and interventricular septal thickness, 
which may indicate the beginning of myocardial hypertrophy 
preceding HCMP. Furthermore, the diastolic measurement of 
mitral inflow, E, E/A, tissue Doppler E’, and E/E’ were all sig-
nificantly different, suggesting that statistically significant dia-
stolic dysfunction had already developed. This diastolic dete-
rioration certainly seems to have preceded the hypertrophic 
change of the myocardium. The decline of diastolic function 
could represent the beginning of real myocardial deterioration. 
Pathological hypertrophy may then progress in the interven-
tricular septum and ventricular posterior free wall along with 
mitochondrial biogenesis to overcome the persistent lack of 
sufficient energy to meet the workload demanded.
To diagnose patients with early cardiac deterioration, diverse 
echocardiographic techniques should be used in patients with 
MD, along with conventional and advanced myocardial imag-
ing studies. Myocardial layer-specific strain analysis is a feasi-
ble and reproducible method to assess subtle myocardial de-
terioration.18 However, to our knowledge, it has rarely been 
used in children. In this study, children with MD demonstrated 
decreased diastolic parameters, compared to those in healthy 
controls. We also tried to perform layer-specific myocardial 
analysis of the endocardium, myocardium, and epicardium in 
this patient population for the first time. Interestingly, we ob-
served circumferential strain deterioration in the myocardium 
and epicardium despite preserved longitudinal and radial strain 
with normal left ventricular ejection fraction. 
Earlier deterioration of circumferential strain may be due to 
the configuration of left ventricular myofibril derangement in 
Fig. 2. Correlation of circumferential strain of the middle myocardial layer with conventional and tissue Doppler parameters.
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patients with MD. As myocardial fiber arrangement is impor-
tant for electrical propagation and myocardial contraction, 
once subtle myofibril dysfunction develops, the conduction 
problem would be unavoidable. Moreover, myofibril dysfunc-
tion is the obvious cause for further contractile dysfunction. In 
other words, decreased circumferential strain could serve as 
an early sign of myocardial dysfunction before it is severe en-
ough to produce clinical detectable changes and while other 
conventional systolic parameters are still within reasonable 
ranges. Therefore, circumferential strain can be a sensitive in-
dicator of myocardial deterioration before the development of 
myocardial fibrosis and the subsequent loss of myocytes. 
Among the three layers of the myocardium, we recognized 
that, in terms of order and severity, circumferential strain al-
teration started from the mid-myocardial layer and progressed 
to the epicardial layer. The endocardial layer may be less dete-
riorated or relatively preserved in terms of functional decline, 
compared with the middle myocardium and epicardium. This 
could indeed be a promising valuable discovery in relation to 
myocardial assessment in pediatric patients with MD. Further-
more, circumferential strain in all three layers correlated well 
with early diastolic tissue Doppler velocity of E’, which may im-
ply systolic and diastolic coupling in these children.
The goal of cardiovascular treatment is to decelerate the de-
terioration of myocardial function with appropriate drugs to al-
low a better quality of life, regardless of systemic multi-organ 
involvement. Even in patients showing values in the normal 
ranges for various parameters of conventional echocardiogra-
phy, advanced detailed functional indicators, such as strain 
measurements, may help to recognize early signs of dysfunc-
tion, as demonstrated in this study.
Myocardial strain analysis of the respective cardiac layers is 
certainly a promising tool with which to detect subtle myocar-
dial deterioration before any noticeable decline of cardiac func-
tion occurs, aiding in determining when to proceed with suit-
able cardiac treatment. It could undoubtedly play a role in the 
enhancement of cardiac function and thus improve prognosis 
with respect to growth and development in children with MD. 
The limitation of this study is a small sample size of the rare 
disease children with MD. Further studies are needed to pro-
vide a better and more comprehensive investigation. 
In conclusion, children with MD may have earlier myocar-
Fig. 3. Correlation of circumferential strain of the epicardial layer with conventional and tissue Doppler parameters.
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dial deterioration in circumferential strain, especially of the 
middle myocardial and epicardial layers, even with well-pre-
served longitudinal function. This knowledge could be used 
as an early diagnostic indicator of myocardial involvement, aid-
ing in diagnosis and allowing for timely treatment of CMP. 
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